Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
Email Facebook Twitter Google+ LinkedIn Comments

Raydiance Inc.

Aug 2007
Raydiance Inc. of Petaluma, Calif., has entered into a two-year cooperative research and development agreement with the FDA. Under the terms of the agreement, the administration will use the company’s software-controlled ultrashort-pulse laser system to analyze the interaction between high-power lasers and tissue. Specifically, the Center for Devices and Radiological Health, the Division of Physics, and the Office of Science and Engineering Laboratories of the FDA will investigate the use, safety and effectiveness of the laser systems in dental, gene transfection, light therapy and ophthalmic applications.

BiophotonicsBusinesshigh-power lasersRapidScanRaydiance Inc.ultrashort-pulse laser systemlasers

Terms & Conditions Privacy Policy About Us Contact Us
back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2019 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA,

Photonics Media, Laurin Publishing
x Subscribe to BioPhotonics magazine - FREE!
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.